Clinical Trial Update: Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the withdrawal of a Phase 1/2 pilot study evaluating intravitreal infliximab for uveitic macular edema and intraocular inflamma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Inflammation
• Uveitic Macular Edema

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Uveitic Macular Edema, Intraocular Inflammation | Phase 1, Phase 2 | Status: WITHDRAWN